Filed in archive
Diagnostics, Methodologies and Instrumentation
, Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on October 23, 2006
Scientists at Duke University's Institute for Genome Sciences & Policy have developed a genomic test to help predict which drugs are suitable for treating a patient's cancerous tumor, based on the tumor's genomic profile.
Preliminary tests indicate that the test is about 80% accurate, and clinical trials are planned for next year. The results of the preliminary study has been published in Nature Medicine (doi:10.1038/nm1491). For an overview, see the press release from Duke University Medical Center.
The new tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy, said Anil Potti, M.D., the study's lead investigator and an assistant professor of medicine in the Duke Institute for Genome Sciences & Policy. The tests are designed to help doctors select and initiate treatment with the best drug for a patient's tumor instead of trying various drugs in succession until the right one is found, Potti said.
Preliminary tests indicate that the test is about 80% accurate, and clinical trials are planned for next year. The results of the preliminary study has been published in Nature Medicine (doi:10.1038/nm1491). For an overview, see the press release from Duke University Medical Center.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/40091
Mr Wong
Vote for Genomic Tests to Guide Choice of Chemotherapy:
|
Rating: 7.33 out of 3 vote(s) cast.
|
Response from:
Julia Schopick
(10/23/06 7:07pm)
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |








Chemosensitvity Testing has been pioneered by both Robert Nagourney, MD and his colleague Larry Weisenthal, MD (www.weisenthal.org), both well known experts/pioneers in the area of this controversial, but well-studied protocol.
Briefly, these physicians test a person's cancer cells outside the body, in vitro, to see which chemotherapies will work best to kill the person's particular cancer.
To read more about Chemosensitivity Testing, you may go to the left side of my website, http://www.honestmedicine.typepad.com.You
will see the link to this treatment under "cutting edge(sometimes controversial) treatments." Or go directly to http://www.rationaltherapeutics.com/
or http://www.weisenthal.org.
I hope you find this treatment interesting, as well.
Thanks.
Julia Schopick
http://www.honestmedicine.typepad.com